Authors:
Blanch, J
Martinez, E
Rousaud, A
Blanco, JL
Garcia-Viejo, MA
Peri, JM
Mallolas, J
De Lazzari, E
De Pablo, J
Gatell, JM
Citation: J. Blanch et al., Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz, J ACQ IMM D, 27(4), 2001, pp. 336-343
Authors:
Martinez, E
Blanco, JL
Arnaiz, JA
Perez-Cuevas, JB
Mocroft, A
Cruceta, A
Marcos, MA
Milinkovic, A
Garcia-Viejo, MA
Mallolas, J
Carne, X
Phillips, A
Gatell, JM
Citation: E. Martinez et al., Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy, AIDS, 15(10), 2001, pp. 1261-1268
Authors:
Martinez, E
Mocroft, A
Garcia-Viejo, MA
Perez-Cuevas, JB
Blanco, JL
Mallolas, J
Bianchi, L
Conget, I
Blanch, J
Phillips, A
Gatell, JM
Citation: E. Martinez et al., Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study, LANCET, 357(9256), 2001, pp. 592-598
Authors:
Mallolas, J
Blanco, JL
Sarasa, M
Giner, V
Martinez, E
Garcia-Viejo, MA
Arnaiz, JA
Cruceta, A
Soy, D
Tuset, M
Soriano, A
Codina, C
Pumarola, T
Carne, X
Gatell, JM
Citation: J. Mallolas et al., Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients, J ACQ IMM D, 25(3), 2000, pp. 229-235
Authors:
Martinez, E
Garcia-Viejo, MA
Blanco, JL
Bianchi, L
Buira, E
Conget, I
Casamitjana, R
Mallolas, J
Gatell, JM
Citation: E. Martinez et al., Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy, CLIN INF D, 31(5), 2000, pp. 1266-1273
Authors:
Martinez, E
Garcia-Viejo, MA
Marcos, MA
Perez-Cuevas, JB
Blanco, JL
Mallolas, J
Miro, JM
Gatell, JM
Citation: E. Martinez et al., Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy, AIDS, 14(16), 2000, pp. 2615-2617